Timing of Low Vision Rehabilitation in Anti- Vascular Endothelial Growth Factor (VEGF) Therapy
NCT03065907
·
clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
3
Enrollment
OTHER
Sponsor class
Conditions
Low Vision
Neovascular Age-related Macular Degeneration
Interventions
OTHER:
Vision rehabilitation
Sponsor
Johns Hopkins University